홍보/게시판

보도자료

아델 뉴스

Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease

작성일
2024-02-26 09:04
PREV 아델·오스코텍, 치매치료제 ‘ADEL-Y01’ 임상 1a상 투약 개시
NEXT After amyloid beta, Adel seeks next big target for Alzheimer’s
목록보기
Powered by KBoard